Q3 2023 TRACON Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals third quarter 2023 earnings conference call. (Operator Instructions)
During today's call, we will be making certain forward-looking statements, including statements regarding expected timing of clinical trials and results, regulatory activities, financing opportunities, future expenses, and cash runway into 2024, our development plans and strategy, potential cost savings deliverable through our product development platform or PDP, ability to enter into additional licensing agreements, and expectations regarding the envafolimab treatment continuing to generate a double-digit objective response rates.
These statements are subject to various risks that are described in our filings made with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2022, and subsequently, quarterly reports on Form 10-Q.
You are cautioned not to place undue reliance on these forward-looking statements. And unless required by applicable law, we disclaim any obligation to update
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |